Академический Документы
Профессиональный Документы
Культура Документы
From Near Extinsion in 1976 India contributes 85% of cases in South East Asia 1st clinical description Hippocrates Elaborated Celsus Peruvian Bark in therapy 17th Century Quinine 1820 Man to Mosquito Cycle Sir Ronald Ross 1998-99
Definition
Complication of plasmodium falciparum Unarousable coma more than 30 mts Exclusion of other causes
Aetio Pathogenesis
Sequestration of Cerebral Capillaries and Venules
Mechanical Hypothesis
Section of brain showing blood vessels blocked with developing P. falciparum parasites
Selective Cytoadherance results in rosetting Reduction of Microvascular Blood flow Hypoxia Dose not explain selective absence of Neurological Deficits
Humoral Hypothesis
Malaria Toxin Stimulates Production of TNF- alpha & Cytokines Stimulate Endothelial cells Uncontrolled production of NO COMA
CLINICAL MANIFASTATIONS
The seasonal Trend
17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0
17
17
13 12 11 11
7 6 4 3 1 0
Jan Fe b Mar Apr May June July Aug Sept Oct Nov Dec
Verbal Response
Eye Movements
Total
0-5
Associated Presentation
Hypoglycaemia Metabolic Acidosis Shock Neurological deficits Other forms can Co-exist
LABORATORY DIAGNOSIS
Stages of P. falciparum
LABORATORY DIAGNOSIS
Contd.
Fluorescence Microscopy (QBC) Nucleic Acid Staining with acridine Parasite Count = (TLC / Cuml X Parasite / 100 WBC) / 100 = Parasite / Cuml of Blood Serology Anti body detection Antigen detection (HRP) Biochemical Test - Optimal test (Parasite LDH) PCR & Culture
CEREBRAL INVOLVEMENT
Clinical CSF - Increased Lactic Acid CT, MRI
THOUGHTS AT BEDSIDE
Haemoglobin
Urobilinogen
THERAPEUTIC OPTIONS
CHEMOTHERAPY
Quinine Artemisinins - Artesunate
- Arte- ether - Arte - mether
NEWER HORIZON
Inhibition of Endothelial Activity
- LMP 420 - Decrease of TNF alpha & LT activity
Vaccine Development